Artwork

Content provided by Syracuse University. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Syracuse University or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Striving to Improve the Efficacy of Obesity, Diabetes Treatments

31:29
 
Share
 

Manage episode 473353089 series 3191565
Content provided by Syracuse University. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Syracuse University or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The cutting-edge weight loss and diabetes research developed by medicinal chemist Robert Doyle has offered significant and consistent weight loss and glucose control to its recipients through peptide-based treatments. Doyle and his fellow collaborators reported that two new peptide compounds­­—GEP44 and KCEM1—considerably reduce body weight and normalize blood glucose levels without causing the typical negative side effects experienced by patients who take currently available GLP-1-based anti-obesity drugs. Doyle, the Jack and Laura H. Milton Professor and Dean's Professor of Chemistry in the College of Arts and Sciences,focuses his research on pharmaceutical drug development for the treatment of obesity and type 2 diabetes. On this episode, Doyle discusses his breakthrough weight loss research, the important role students play in advancing his research, and how, through philanthropy, his work has come to life.

  continue reading

177 episodes

Artwork
iconShare
 
Manage episode 473353089 series 3191565
Content provided by Syracuse University. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Syracuse University or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The cutting-edge weight loss and diabetes research developed by medicinal chemist Robert Doyle has offered significant and consistent weight loss and glucose control to its recipients through peptide-based treatments. Doyle and his fellow collaborators reported that two new peptide compounds­­—GEP44 and KCEM1—considerably reduce body weight and normalize blood glucose levels without causing the typical negative side effects experienced by patients who take currently available GLP-1-based anti-obesity drugs. Doyle, the Jack and Laura H. Milton Professor and Dean's Professor of Chemistry in the College of Arts and Sciences,focuses his research on pharmaceutical drug development for the treatment of obesity and type 2 diabetes. On this episode, Doyle discusses his breakthrough weight loss research, the important role students play in advancing his research, and how, through philanthropy, his work has come to life.

  continue reading

177 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play